Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Essilor presents on Myopia Control & Essilor® Stellest® lenses - featuring guest speakers. Duration:60 minutes featuring 3 presenters, Dr Kate Gifford, Amy Pillay & Oliver Woo.
Synopsis: This session will outline a clear pathway for prescribing Essilor® Stellest® lenses as part of a myopia management strategy. Attendees will gain insights into the five-year clinical studies and supporting research. The session will also cover practical guidance on using Essilor® Stellest® lenses and prescribing Essilor® Stellest® sunglasses. Case study presentations will enhance the learning experience. Learning Objectives
Increase confidence in prescribing Myopia management and adopting a strategy.
The latest clinical studies and supporting research on the Essilor® Stellest® lenses.
The importance of UV protection and Essilor® Stellest® lens sun tint options.
Dr Kate Gifford presents on Delaying myopia onset in pre-myopia
Synopsis:
Proactive myopia management has become the standard of care for young patients with progressive myopia. Lesser recognized in the clinical setting is the impact of managing children at risk of onset, with research showing that a one-year delay in the onset of myopia could result in around 0.75D less final myopia, equivalent to two to three years of currently available myopia treatments. This lecture will explore the definition of pre-myopia, including the new concept of ‘hyperopic reserve’; risk factor identification and the emerging evidence-base on treatment options including pharmaceutical, optical and light therapies. Clinical considerations and communication advice will also be provided.
Learning Outcomes: Upon completion, participants will be able to:
· Describe the identification of pre-myopia and relevant predictive risk factors
· Explain atropine, optical and light therapies for delaying myopia as researched in randomized controlled trials
· Discuss treatment considerations in pre-myopia management and how this translates to clinical approaches and communication
The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.
We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy.
